Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired downregulation of p21(Cip1/WAF1).

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V93.1.25.401A47_25_33PMID 9864142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinoma

  2004cited by this paper
• CXC chemokines and angiogenesis/angiostasis.

  1998cited by this paper
• p53-Dependent Elevation of p21Waf1Expression by UV Light Is Mediated through mRNA Stabilization and Involves a Vanadate-Sensitive Regulatory System

  1998cited by this paper
• New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides.

  1998cited by this paper
• Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes

  1998cited by this paper
• Syndecan-4 Proteoglycan Cytoplasmic Domain and Phosphatidylinositol 4,5-Bisphosphate Coordinately Regulate Protein Kinase C Activity*

  1998cited by this paper
• Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization.

  1998cited by this paper
• Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)

  1998cited by this paper
• Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases.

  1998cited by this paper
• Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs.

  1997cited by this paper
• From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen.

  1997cited by this paper
• Developmental response by Leydig cells to acidic and basic fibroblast growth factor.

  1997cited by this paper
• Syndecan-4 Proteoglycan Regulates the Distribution and Activity of Protein Kinase C*

  1997cited by this paper
• Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells.

  1997cited by this paper
• [Angiogenesis and cancer].

  1997cited by this paper
• Platelet Factor 4 Binds to Glycanated Forms of Thrombomodulin and to Protein C

  1997cited by this paper
• Transcytosis and surface presentation of IL-8 by venular endothelial cells.

  1997cited by this paper
• Angiogenèse et cancer

  1997cited by this paper
• The restriction point and control of cell proliferation.

  1997cited by this paper
• Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth

  1997cited by this paper
• Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate*

  1997cited by this paper
• Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

  1997cited by this paper
• Chemokines.

  1997cited by this paper
• Cdk inhibitors in development and cancer.

  1996cited by this paper
• Regulation of p21WAF1/CIP1 expression by p53-independent pathways.

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells.

  1996cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.

  1995cited by this paper
• The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor

  1995cited by this paper
• The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*)

  1995cited by this paper
• Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.

  1995cited by this paper
• AU-rich elements: characterization and importance in mRNA degradation.

  1995cited by this paper
• Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.

  1995cited by this paper
• Inhibition of cyclin-dependent kinases by p21.

  1995cited by this paper
• A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.

  1995cited by this paper
• Chemokine Class Differences in Binding to the Duffy Antigen-Erythrocyte Chemokine Receptor (*)

  1995cited by this paper
• The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation

  1995cited by this paper
• Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4.

  1995cited by this paper
• Platelet Factor-4 Inhibits the Mitogenic Activity of VEGF121 and VEGF165 Using Several Concurrent Mechanisms (*)

  1995cited by this paper
• Selective binding of platelet factor 4 to regions of active angiogenesis in vivo.

  1995cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect (*)

  1995cited by this paper
• D-type cyclins.

  1995cited by this paper
• Hepatic arterial infusion of recombinant platelet factor‐4 suppresses metastases to the lungs from tumors implanted into the livers of rabbits

  1995cited by this paper
• Principles of CDK regulation

  1995cited by this paper
• Mechanism of action of the immunosuppressant rapamycin.

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?

  1995cited by this paper
• Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF.

  1994cited by this paper
• G1 phase progression: cycling on cue.

  1994cited by this paper
• Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

  1994cited by this paper
• Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.

  1994cited by this paper
• Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor.

  1994cited by this paper
• Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression

  1994cited by this paper
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

  1994cited by this paper
• Induction of WAF1/CIP1 by a p53-independent pathway.

  1994cited by this paper
• The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• COMPARATIVE ANALYSIS OF THE HUMAN MACROPHAGE INFLAMMATORY PROTEIN FAMILY OF CYTOKINES (CHEMOKINES) ON PROLIFERATION OF HUMAN MYELOID PROGENITOR CELLS

  1993cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.

  1993cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• The retinoblastoma protein and the cell cycle.

  1992cited by this paper
• Properties of the novel proinflammatory supergene "intercrine" cytokine family.

  1991influential reference
• Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity.

  1991cited by this paper
• Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells.

  1990cited by this paper
• Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4.

  1990cited by this paper
• Altered levels of endogenous retrovirus‐like sequence (VL30) RNA during mouse epidermal cell carcinogenesis

  1990cited by this paper
• Growth Inhibition of Murine Melanoma and Human Colon Carcinoma by Recombinant Human Platelet Factor 4

  1990cited by this paper
• Platelet factor 4 inhibits human megakaryocytopoiesis in vitro.

  1990cited by this paper
• Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides.

  1990cited by this paper
• Interaction of platelet factor four with cultured vascular endothelial cells.

  1989cited by this paper
• Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product.

  1989cited by this paper
• The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.

  1989cited by this paper
• Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line.

  1987cited by this paper
• Cultivation of endothelial cells: limitations and perspectives.

  1986cited by this paper
• Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity.

  1985cited by this paper
• Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.

  1984cited by this paper
• Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.

  1984cited by this paper
• Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.

  1982cited by this paper
• Evidence that Vascular Endothelial Cells Can Induce the Retraction of Fibrin Clots

  1981cited by this paper
• Binding of platelet factor 4 to cultured human umbilical vein endothelial cells.

  1980cited by this paper

• The central role of CXCL10-CXCR3 signaling in neuroinflammation and neuropathology.

  2025cites this paper
• Platelet factors ameliorate thoracic aortic aneurysm and dissection by inhibiting the FGF-FGFR cascade activation in aortic-endothelial cell

  2024cites this paper
• Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies.

  2021cites this paper
• Effects of CXCL4/CXCR3 on the lipopolysaccharide‐induced injury in human umbilical vein endothelial cells

  2019cites this paper
• Optimizing culture conditions for hepatic differentiation of human inducedpluripotent stem cells: from 3D culture systems to co-cultures

  2018cites this paper
• Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization

  2018cites this paper
• Anti-CXCL4 monoclonal antibody accelerates telogen to anagen transition and attenuates apoptosis of the hair follicle in mice

  2017cites this paper
• Effects of Co-Culture Media on Hepatic Differentiation of hiPSC with or without HUVEC Co-Culture

  2017cites this paper
• eview egulatory role of Megakaryocytes on Hematopoietic Stem Cells uiescence by CXCL 4 / PF 4 in Bone Marrow Niche

  2016cites this paper
• Regulatory role of Megakaryocytes on Hematopoietic Stem Cells Quiescence by CXCL4/PF4 in Bone Marrow Niche.

  2016cites this paper
• PLATELET ANGIOGENIC ACTIVITIES AND THEIR REGULATION ON ENDOTHELIAL PROGENITOR CELL FUNCTIONS

  2015cites this paper
• Angiostatic, tumor inflammatory and anti-tumor effects of CXCL447–70 and CXCL4L147–70 in an EGF-dependent breast cancer model

  2014cites this paper
• Relationship between Platelet Aggregatory and Heparin-Induced Thrombocytopenia Type II

  2014cites this paper
• Platelet factor 4 protects bone marrow mesenchymal stem cells from acute radiation injury.

  2014cites this paper
• Platelet factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy.

  2013cites this paper
• (Nonregulatory) T Cells -(Regulatory) versus CD4+CD25 Platelet Factor 4 Differentially Modulates

  2013cites this paper
• IL-12-dependent innate immunity arrests endothelial cells in G0–G1 phase by a p21Cip1/Waf1-mediated mechanism

  2012cites this paper
• Megakaryocytes, malignancy and bone marrow vascular niches

  2012cites this paper
• Anti-angiogenic gene therapy in the treatment of malignant gliomas.

  2012cites this paper
• CXC chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes

  2012cites this paper
• The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.

  2011cites this paper
• Rational Design and Development of Anti- Angiogenic Protein Agents

  2011cites this paper
• CXCL4L1 inhibits angiogenesis and induces undirected endothelial cell migration without affecting endothelial cell proliferation and monocyte recruitment

  2011cites this paper
• Structural and functional characterization of the interactions of platelet derived chemokines CCL5, CXCL4 and CXCL4L1

  2011cites this paper
• Regulation of angiostatic chemokines driven by IL‐12 and IL‐27 in human tumors

  2011cites this paper
• Tumor Angiogenesis: Insights and Innovations

  2010cites this paper
• Platelet-derived chemokines: pathophysiology and therapeutic aspects

  2010cites this paper
• The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo

  2010cites this paper
• In vivo Suppresses B 16 Melanoma Growth ) Strongly Inhibits Angiogenesis and 47-70 ( CXCL 4 L 1 / PF-4 var The COOH-Terminal Peptide of Platelet Factor-4 Variant

  2010cites this paper
• Interactions Between Megakaryocytes and Tumour Cells at the Bone Marrow Vascular Stem Cell Niche Promote Tumour Growth and Metastasis.

  2009cites this paper
• CXC Chemokines in Cancer Angiogenesis

  2009cites this paper
• Therapeutic efficacy of recombinant human endostatin combined with chemotherapeutics in mice-transplanted tumors.

  2009cites this paper
• The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis

  2008cites this paper
• Chemokines in Angiogenesis

  2008cites this paper
• Pulmonary Angiogenesis in Neoplastic and Nonneoplastic Disorders

  2008cites this paper
• Platelet Factor 4 (CXC Chemokine Ligand 4) Differentially Regulates Respiratory Burst, Survival, and Cytokine Expression of Human Monocytes by Using Distinct Signaling Pathways1

  2007cites this paper
• Platelet Factor 4 ( CXC Chemokine Ligand 4 ) Differentially Regulates Respiratory Burst , Survival , and Cytokine Expression of Human Monocytes by Using Distinct Signaling Pathways 1

  2007cites this paper
• Chemokines as mediators of angiogenesis

  2007cites this paper
• Molecular pathways of angiogenesis inhibition.

  2007cites this paper
• Pathways Monocytes by Using Distinct Signaling Survival , and Cytokine Expression of Human Differentially Regulates Respiratory Burst , Platelet Factor 4 ( CXC Chemokine Ligand 4 )

  2007cites this paper
• CCR7 Signaling Inhibits T Cell Proliferation1

  2007cites this paper
• Chemokines and Angiogenesis

  2007cites this paper
• Role of Pertussis Toxin-sensitive G Protein-coupled Receptor Signaling in the Proliferation of Bone Marrow Mesenchymal Stem Cells

  2007cites this paper
• CCR7 Signaling Inhibits T Cell Proliferation

  2007cites this paper
• Analysis of the VEGFR1 (FLT -1) isoforms in vascular development

  2006cites this paper
• Activation of Platelet Function Through G Protein–Coupled Receptors Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease In Vivo Thrombus Formation Platelet Adhesion Platelet Inhibitors and Thrombus Formation

  2006cites this paper
• Influence of angiogenesis inhibitors on endothelial cell morphology in vitro

  2006cites this paper
• Roles of platelet factor 4 in hematopoiesis and angiogenesis

  2006influential citation
• Inhibition of angiogenesis by vitamin D-binding protein: Characterization of anti-endothelial activity of DBP-maf

  2006cites this paper
• Chemokine receptors in tissue cells and angiogenesis

  2006cites this paper
• Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy.

  2006cites this paper
• Neutrophil adhesion to endothelial cells induced by platelet factor 4 requires sequential activation of Ras, Syk, and JNK MAP kinases.

  2006cites this paper
• Platelet Factor 4 Differentially Modulates CD4 CD25 (Regulatory) versus CD4 CD25 (Nonregulatory) T Cells

  2005cites this paper
• Neutrophil adhesion to endothelial cells induced by platelet factor 4 (PF4; CXCL4) requires sequential activation of Ras, Syk, and JNK MAP kinases

  2005cites this paper
• CXC chemokines in angiogenesis.

  2005cites this paper
• CXC Chemokines in Cancer

  2005cites this paper
• Neutrophil adhesion to endothelial cells induced by platelet factor 4 ( PF 4 ; CXCL 4 ) requires sequential activation of Ras , Syk , and JNK MAP kinases

  2005cites this paper
• Platelet Factor 4 Differentially Modulates CD4+CD25+ (Regulatory) versus CD4+CD25− (Nonregulatory) T Cells1

  2005cites this paper
• CKβ8-1 alters expression of cyclin E in colony forming units-granulocyte macrophage (CFU-GM) lineage from human cord blood CD34+ cells

  2005cites this paper
• 3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice.

  2005cites this paper
• Chemokine expression and regulation of angiogenesis in rheumatoid arthritis.

  2005cites this paper
• CKbeta8-1 alters expression of cyclin E in colony forming units-granulocyte macrophage (CFU-GM) lineage from human cord blood CD34+ cells.

  2005cites this paper
• Platelet factor 4 disrupts the intracellular signalling cascade induced by vascular endothelial growth factor by both KDR dependent and independent mechanisms.

  2004cites this paper
• Recent developments in the inhibition of angiogenesis: examples from studies on platelet factor-4 and the VEGF/VEGFR system.

  2004cites this paper
• Platelet Factor 4: An Inhibitor of Angiogenesis

  2004cites this paper
• The control of angiogenesis and tumor invasion by platelet factor-4 and platelet factor-4-derived molecules.

  2004cites this paper
• The Control of Angiogenesis and Tumor Invasion by Platelet Factor-4 and Platelet Factor-4-Derived Molecules

  2004cites this paper
• Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis

  2004cites this paper
• CXC chemokines: the regulatory link between inflammation and angiogenesis.

  2004cites this paper
• Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment?

  2003cites this paper
• Thrombospondins 1 and 2 function as inhibitors of angiogenesis.

  2003cites this paper
• Molecular targets in the inhibition of angiogenesis

  2003cites this paper
• [Heparin induced thrombocytopenia].

  2003cites this paper
• An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4

  2003cites this paper
• Tissue specific differences between endothelia : expression and presentation of chemokines and their receptors.

  2003cites this paper
• Cell surface heparan sulfate participates in CXCL1-induced signaling.

  2003cites this paper
• The guanylate binding protein-1

  2003cites this paper
• Analysis of the role of chemokines in angiogenesis.

  2003cites this paper
• Chemokines in Lung Cancer

  2003cites this paper
• Inhibitors of Angiogenesis

  2002cites this paper
• Signal Transduction of Chemokine Platelet Factor 4 in Human Erythroleukemia Cells

  2002cites this paper
• Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases.

  2002cites this paper
• Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.

  2002cites this paper
• Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNF alpha-308A allele in children with juvenile dermatomyositis.

  2002cites this paper
• Chapter 2.6 – CXC Chemokines in Angiogenesis

  2002cites this paper
• The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells.

  2001cites this paper
• Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro

  2001cites this paper
• Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.

  2001cites this paper
• A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF‐2

  2001cites this paper
• CXC chemokines in angiogenesis

  2000cites this paper
• I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo.

  2000cites this paper
• Chemokine Receptors and Their Role in Vascular Biology

  2000cites this paper
• Chemokine signaling in inflammation

  2000cites this paper
• Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells.

  2000cites this paper
• Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.

  2000influential citation